JP2014524464A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524464A5
JP2014524464A5 JP2014526594A JP2014526594A JP2014524464A5 JP 2014524464 A5 JP2014524464 A5 JP 2014524464A5 JP 2014526594 A JP2014526594 A JP 2014526594A JP 2014526594 A JP2014526594 A JP 2014526594A JP 2014524464 A5 JP2014524464 A5 JP 2014524464A5
Authority
JP
Japan
Prior art keywords
oxo
carboxamide
tetrahydroisoquinoline
pyrazol
isobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014526594A
Other languages
English (en)
Japanese (ja)
Other versions
JP6035334B2 (ja
JP2014524464A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/054305 external-priority patent/WO2013027196A1/en
Publication of JP2014524464A publication Critical patent/JP2014524464A/ja
Publication of JP2014524464A5 publication Critical patent/JP2014524464A5/ja
Application granted granted Critical
Publication of JP6035334B2 publication Critical patent/JP6035334B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014526594A 2011-08-25 2012-08-24 抗マラリア療法のための置換2−アルキル−1−オキソ−n−フェニル−3−ヘテロアリール−1,2,3,4−テトラヒドロイソキノリン−4−カルボキサミド Expired - Fee Related JP6035334B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161527594P 2011-08-25 2011-08-25
US61/527,594 2011-08-25
PCT/IB2012/054305 WO2013027196A1 (en) 2011-08-25 2012-08-24 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies

Publications (3)

Publication Number Publication Date
JP2014524464A JP2014524464A (ja) 2014-09-22
JP2014524464A5 true JP2014524464A5 (enExample) 2015-09-03
JP6035334B2 JP6035334B2 (ja) 2016-11-30

Family

ID=47018313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014526594A Expired - Fee Related JP6035334B2 (ja) 2011-08-25 2012-08-24 抗マラリア療法のための置換2−アルキル−1−オキソ−n−フェニル−3−ヘテロアリール−1,2,3,4−テトラヒドロイソキノリン−4−カルボキサミド

Country Status (19)

Country Link
US (1) US9416124B2 (enExample)
EP (1) EP2748147B1 (enExample)
JP (1) JP6035334B2 (enExample)
CN (1) CN103930404B (enExample)
BR (1) BR112014004437B1 (enExample)
CA (1) CA2846507C (enExample)
CY (1) CY1119748T1 (enExample)
DK (1) DK2748147T3 (enExample)
ES (1) ES2644082T3 (enExample)
HR (1) HRP20171567T1 (enExample)
HU (1) HUE034721T2 (enExample)
LT (1) LT2748147T (enExample)
ME (1) ME02908B (enExample)
PL (1) PL2748147T3 (enExample)
PT (1) PT2748147T (enExample)
RS (1) RS56544B1 (enExample)
SI (1) SI2748147T1 (enExample)
SM (1) SMT201700528T1 (enExample)
WO (1) WO2013027196A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111886225A (zh) * 2017-08-21 2020-11-03 纳维根公司 Arf6抑制剂及相关方法
EP3892332A1 (en) 2020-04-09 2021-10-13 University Of Kentucky Research Foundation New anti-malarial agents
CA3214899A1 (en) 2021-04-15 2022-10-20 Lutz Weber Isoquinoline derivatives for use as antiviral and antitumour agents
EP4074314A1 (en) 2021-04-15 2022-10-19 Valdospan GmbH Isoquinoline derivatives for use as antiviral and antitumour agents
AU2023363824A1 (en) 2022-10-17 2025-04-17 Rdp Pharma Ag Isoquinoline derivatives as protein degraders, e7 degraders, antivirals, tumor therapeutics and immune suppressives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409938A (en) * 1994-02-14 1995-04-25 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
US5639761A (en) * 1994-02-14 1997-06-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
US6921762B2 (en) * 2001-11-16 2005-07-26 Amgen Inc. Substituted indolizine-like compounds and methods of use
WO2004004727A1 (en) 2002-07-03 2004-01-15 Axys Pharmaceuticals, Inc. 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis
DE10237722A1 (de) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
DE10312963A1 (de) 2003-03-24 2004-10-07 Aventis Pharma Deutschland Gmbh Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
UY29440A1 (es) * 2005-03-25 2006-10-02 Glaxo Group Ltd Nuevos compuestos
RU2302417C1 (ru) * 2006-03-14 2007-07-10 Иващенко Андрей Александрович 1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека
BRPI0912871A2 (pt) * 2008-05-19 2015-10-20 Actelion Pharmaceuticals Ltd novas tetraidroisoquinolinas como agentes antimaláricos.
GB0820856D0 (en) 2008-11-14 2008-12-24 Univ Leuven Kath Novel inhibitors of flavivirus replication

Similar Documents

Publication Publication Date Title
AU2012382875B2 (en) Compound as WNT signaling inhibitor, composition, and use thereof
JP4216196B2 (ja) Npyアンタゴニストとしてのキノリン誘導体
JP2014508811A5 (enExample)
JP2014524464A5 (enExample)
JP2019031560A5 (enExample)
JP2009524670A5 (enExample)
WO2012122340A1 (en) Soluble guanylate cyclase activators
JP2018531921A (ja) B型肝炎ウイルスコアタンパク質モジュレーター
JP2016522835A5 (enExample)
JP2017533968A5 (enExample)
JP2013531074A5 (enExample)
JP2012532112A5 (enExample)
JP2005508313A5 (enExample)
JP2016513660A5 (enExample)
JP2016500661A5 (enExample)
JP2012507535A5 (enExample)
JP2008513516A5 (enExample)
JP2011500550A5 (enExample)
JP2015531774A5 (enExample)
JP2013537203A5 (enExample)
JP2017528506A5 (enExample)
JP2017504635A5 (enExample)
JP2016500063A5 (enExample)
JP2019531279A5 (enExample)
JP2017505293A5 (enExample)